GL1X · GenesisL1 explorer

MolNFT v1 · #179803 · protein

Crystal structure of synthetic nanobody (SB45) complexes with SARS- cov-2 receptor binding domain

7KGJ · Spike glycoprotein: “Crystal structure of synthetic nanobody (SB45) complexes with SARS- cov-2 receptor binding domain”. X-ray diffraction, 2 pockets (best druggability 0.44). MolNFT v1 #179803 on GenesisL1: 3D structure, binding…

PDB
7KGJ
Type
protein
Length
317 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Spike glycoprotein; SB45, sybody-45, synthetic nanobody
UniProt
P0DTC2
Pockets
2 · best druggability 0.44

Structure

x-ray diffraction · 2 distinct chains · 13% helix, 39% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ASpike glycoproteinprotein19618% helix, 30% strandP0DTC2
BSB45, sybody-45, synthetic nanobodyprotein1215% helix, 55% strand—

Pockets

2 pockets found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11110.440.7825empty
2720.340.7615empty

Interfaces

1 interface between chains.

  • A–B · 1044 Ų buried · 17 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 5 disulfide (disulfide).

Compared structures

  • 7KGJ · Crystal structure of synthetic nanobody (Sb45) complexes with SARS-CoV-2 receptor binding… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.